A preclinical model to assess the antige
β
Yoshihiko Hayashi; Dave S. B. Hoon; Leland J. Foshag; Min S. Park; Paul I. Teras
π
Article
π
1993
π
John Wiley and Sons
π
English
β 876 KB
Background. The authors have demonstrated that immunization with melanoma whole-cell vaccine (MCV) augments T-cell responses to melanoma and that cytotoxic T-cells (CTL) recognize allogeneic melanoma-bearing shared HLA-A antigens. A preclinical model was developed to assess CTL activation in vitro u